Vascular Biogenics Ltd. (NASDAQ: VBLT) open the trading on November 23, 2022, with great promise as it jumped 9.75% to $0.15. During the day, the stock rose to $0.1633 and sunk to $0.1363 before settling in for the price of $0.14 at the close. Taking a more long-term approach, VBLT posted a 52-week range of $0.11-$2.38.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
Meanwhile, its Annual Earning per share during the time was 6.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.70%. This publicly-traded company’s shares outstanding now amounts to $77.40 million, simultaneously with a float of $53.76 million. The organization now has a market capitalization sitting at $10.67 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1442, while the 200-day Moving Average is $0.9404.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 41 employees. For the Profitability, stocks gross margin was -111.07, operating margin was -3905.73 and Pretax Margin of -3895.83.
Vascular Biogenics Ltd. (VBLT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vascular Biogenics Ltd.’s current insider ownership accounts for 22.48%, in contrast to 17.10% institutional ownership.
Vascular Biogenics Ltd. (VBLT) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2022 suggests? It has posted -$0.12 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.1) by -$0.02. This company achieved a net margin of -3895.83 while generating a return on equity of -72.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
Vascular Biogenics Ltd.’s EPS increase for this current 12-month fiscal period is 18.70% and is forecasted to reach -0.47 in the upcoming year.
Vascular Biogenics Ltd. (NASDAQ: VBLT) Trading Performance Indicators
Let’s observe the current performance indicators for Vascular Biogenics Ltd. (VBLT). It’s Quick Ratio in the last reported quarter now stands at 4.10. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 17.79.
In the same vein, VBLT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.47, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.47 at the market close of one year from today.
Technical Analysis of Vascular Biogenics Ltd. (VBLT)
[Vascular Biogenics Ltd., VBLT] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 80.88% While, its Average True Range was 0.0145.